Note
Spontaneous formation of drug-containing amphiphilic β-cyclodextrin nanocapsules

https://doi.org/10.1016/S0378-5173(96)04756-4Get rights and content

Abstract

A new colloidal carrier system, nanocapsules, using 2,3-diacyl-O-β-cyclodextrins is described. The nanocapsules were prepared by adding a mixture of an organic solution of 2,3-diacyl-O-β-cyclodextrins (with or without a lipophilic surfactant) and an oily phase to an aqueous solution (with or without a hydrophilic surfactant) whilst stirring. Nanocapsules with a mean size of 200 nm are formed progressively. Direct microscopic observation of the particles was carried out using transmission electron microscopy (TEM) combined with the freeze-fracture method. The influence of different constituents on the preparation process was studied: type of 2,3-diacyl-O-β-cyclodextrins (β-CD-C6, β-CD-C12 and β-CD-C14), nature of the oily phase (benzyl benzoate, Miglyol 812®), and the surfactants used (Pluronic PEF68®, Span 85®). An investigation of lipophilic drug encapsulation was also carried out. The results of this study suggest that nanocapsules of 2,3-diacyl-O-β-cyclodextrins could be considered as a potential colloidal drug carrier system.

Cited by (0)

View full text